X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (78825) 78825
Book Review (12880) 12880
Publication (7327) 7327
Newsletter (6350) 6350
Newspaper Article (3282) 3282
Book Chapter (541) 541
Conference Proceeding (381) 381
Dissertation (184) 184
Magazine Article (169) 169
Transcript (152) 152
Government Document (112) 112
Book / eBook (71) 71
Web Resource (60) 60
Trade Publication Article (56) 56
Reference (10) 10
Streaming Video (9) 9
Data Set (7) 7
Report (4) 4
Presentation (3) 3
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (62044) 62044
angiogenesis (52821) 52821
humans (50029) 50029
animals (30048) 30048
cancer (21407) 21407
female (21376) 21376
oncology (21243) 21243
male (20005) 20005
mice (16895) 16895
angiogenesis inhibitors (15912) 15912
vascular endothelial growth factor (14433) 14433
expression (13471) 13471
research (12222) 12222
endothelial growth-factor (12084) 12084
angiogenesis inhibitors - therapeutic use (11708) 11708
metastasis (11061) 11061
middle aged (10647) 10647
apoptosis (10132) 10132
care and treatment (9720) 9720
aged (9475) 9475
tumors (9339) 9339
bevacizumab (8779) 8779
cell biology (8746) 8746
analysis (8467) 8467
cell line, tumor (8435) 8435
proteins (8341) 8341
adult (7513) 7513
biochemistry & molecular biology (7030) 7030
gene expression (6987) 6987
cells (6980) 6980
angiogenesis inhibitors - pharmacology (6960) 6960
ophthalmology (6721) 6721
vegf (6709) 6709
neovascularization (6470) 6470
growth (6324) 6324
signal transduction (6262) 6262
pharmacology & pharmacy (6165) 6165
health aspects (6147) 6147
chemotherapy (6113) 6113
cells, cultured (5913) 5913
rats (5599) 5599
treatment outcome (5572) 5572
kinases (5568) 5568
vascular endothelial growth factor a - antagonists & inhibitors (5568) 5568
therapy (5370) 5370
angiogenesis inhibitors - administration & dosage (5334) 5334
cell proliferation (5279) 5279
vascular endothelial growth factor a - metabolism (5279) 5279
in-vivo (5256) 5256
tumor angiogenesis (5123) 5123
rodents (5026) 5026
endothelium (5015) 5015
medicine (4980) 4980
physiological aspects (4895) 4895
inflammation (4843) 4843
activation (4839) 4839
research article (4793) 4793
hypoxia (4786) 4786
medicine, research & experimental (4777) 4777
in-vitro (4764) 4764
cell proliferation - drug effects (4763) 4763
article (4732) 4732
inhibition (4648) 4648
immunohistochemistry (4598) 4598
endothelial cells (4481) 4481
breast cancer (4460) 4460
development and progression (4349) 4349
neovascularization, pathologic - drug therapy (4347) 4347
multidisciplinary sciences (4299) 4299
studies (4299) 4299
aged, 80 and over (4154) 4154
cancer therapies (4002) 4002
medical research (3987) 3987
medicine & public health (3968) 3968
proliferation (3947) 3947
genetic aspects (3911) 3911
disease models, animal (3863) 3863
antineoplastic agents - therapeutic use (3837) 3837
mice, nude (3808) 3808
prognosis (3759) 3759
mice, inbred c57bl (3712) 3712
phosphorylation (3686) 3686
carcinoma (3659) 3659
tumor-growth (3595) 3595
endothelial-cells (3568) 3568
biology (3567) 3567
stem cells (3545) 3545
cell growth (3533) 3533
antineoplastic agents - pharmacology (3531) 3531
surgery (3529) 3529
science (3500) 3500
drug therapy (3468) 3468
breast-cancer (3458) 3458
hematology (3438) 3438
macular degeneration (3437) 3437
abridged index medicus (3424) 3424
growth-factor (3399) 3399
growth factors (3238) 3238
antibodies, monoclonal, humanized (3190) 3190
neoplasms - drug therapy (3189) 3189
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (36) 36
Gerstein Science - Stacks (28) 28
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (87379) 87379
French (550) 550
German (437) 437
Chinese (340) 340
Japanese (270) 270
Spanish (169) 169
Polish (93) 93
Russian (91) 91
Portuguese (56) 56
Korean (54) 54
Hungarian (37) 37
Czech (34) 34
Italian (24) 24
Romanian (22) 22
Dutch (18) 18
Turkish (14) 14
Swedish (13) 13
Danish (11) 11
Finnish (10) 10
Hebrew (8) 8
Norwegian (6) 6
Persian (5) 5
Croatian (4) 4
Slovak (4) 4
Serbian (3) 3
Ukrainian (3) 3
Icelandic (2) 2
Slovenian (2) 2
Arabic (1) 1
Bosnian (1) 1
Hindi (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, ISBN 1402095635, ix, 125
In 1971, J. Folkman published in the "New England Journal of Medicine" a hypothesis that tumor growth is angiogenesis-dependent. Folkman introduced the concept... 
Neovascularization | Blood-vessels | Growth | Neovascularization inhibitors | Tumors | Clinical & internal medicine | Treatment | Pathology | History of Science | Biomedicine | Cancer Research | Oncology | Biomedicine general | Cell Biology
Book
2010, Recent results in cancer research, ISBN 9783540782803, Volume 180., xiv, 231
All aspects from the bench to the bedside are considered in this examination of the latest developments in angiogenesis inhibition in cancer. The authors pay... 
Neovascularization inhibitors | Chemotherapy | Therapeutic use | Cancer | Oncology | Cancer Research | Medicine & Public Health | Hematology
Book
Nature, ISSN 0028-0836, 03/2015, Volume 519, Issue 7541, pp. 102 - 105
The BCR-ABL1 fusion gene is a driver oncogene in chronic myeloid leukaemia and 30-50% of cases of adult acute lymphoblastic leukaemia(1). Introduction of ABL1... 
MECHANISM | POSITIVE LEUKEMIA | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | RESISTANCE | FOLLOW-UP | PATIENTS RECEIVING IMATINIB | KINASE INHIBITOR | BCR-ABL INHIBITOR | CHRONIC MYELOID-LEUKEMIA | T315I MUTANT | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Humans | Molecular Conformation | Imidazoles - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Crystallography, X-Ray | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Protein Kinase Inhibitors - chemistry | Angiogenesis Inhibitors - therapeutic use | Imidazoles - therapeutic use | Phosphorylation - drug effects | Fusion Proteins, bcr-abl - chemistry | Cell Line | Proto-Oncogene Proteins c-abl - genetics | Indazoles - chemistry | Crystallization | Proto-Oncogene Proteins c-abl - chemistry | Angiogenesis Inhibitors - pharmacology | Models, Molecular | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Imidazoles - pharmacology | Drug Repositioning | Indazoles - pharmacology | Drug Resistance, Neoplasm - genetics | Fusion Proteins, bcr-abl - genetics | Vascular Endothelial Growth Factor Receptor-2 - chemistry | Protein Kinase Inhibitors - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Protein Binding | Proto-Oncogene Proteins c-abl - metabolism | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Kidney Neoplasms - drug therapy | Fusion Proteins, bcr-abl - metabolism | Indazoles - therapeutic use | Angiogenesis Inhibitors - chemistry | Drug Screening Assays, Antitumor | Axitinib | Genetic aspects | Research | Gene mutations | Drug resistance | Analysis | Phosphorylation | Inhibitor drugs | Leukemia | Bone marrow | Mutation | Kinases | Drug dosages | Patients | Index Medicus
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2015, Volume 171, Issue 5, pp. 798 - 812
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 05/2011, Volume 286, Issue 21, pp. 18633 - 18640
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 08/2016, Volume 118, pp. 250 - 258
Two new series of 1,5-diaryl pyrazoles ( , , , and ) and 1,5-diaryl pyrazoline ( and were prepared as both Cyclooxygenase-2 and 15-lipoxygenase inhibitors.... 
15-Lipoxygenase inhibitors | Ethyl trifloroacetate | SO2NH2 pharmacophores | Cyclooxygenase inhibitors | Celecoxib analogues | DMFDMA | Anti-inflammatory | pharmacophores | CHEMISTRY, MEDICINAL | COX-2 | LEUKOTRIENES | CYCLOOXYGENASE | PROSTAGLANDINS | INFLAMMATION | BIOLOGICAL EVALUATION | AGENTS | 5-LIPOXYGENASE | MEDIATORS | DERIVATIVES | Stereoisomerism | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Male | Cyclooxygenase 2 Inhibitors - chemistry | Celecoxib - chemistry | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Cyclooxygenase 2 Inhibitors - adverse effects | Lipoxygenase Inhibitors - chemical synthesis | Pyrazoles - chemistry | Lipoxygenase Inhibitors - chemistry | Cattle | Celecoxib - chemical synthesis | Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis | Celecoxib - adverse effects | Cyclooxygenase 2 Inhibitors - chemical synthesis | Chemistry Techniques, Synthetic | Cyclooxygenase 2 Inhibitors - pharmacology | Magnetic Resonance Spectroscopy | Rats | Celecoxib - pharmacology | Arachidonate 15-Lipoxygenase - metabolism | Lipoxygenase Inhibitors - adverse effects | Ulcer - chemically induced | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Cyclization | Cyclooxygenase 2 - metabolism | Thiazoles - chemistry | Lipoxygenase Inhibitors - pharmacology | COX-2 inhibitors | Carrageenin | Nuclear magnetic resonance | Celecoxib | Angiogenesis inhibitors | Liability (Law) | Index Medicus
Journal Article
Annals of Oncology, ISSN 0923-7534, 2011, Volume 22, Issue 6, pp. 1374 - 1381
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 780 - 787
Journal Article